In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
April 7th, 2010 | 24 | No |
Popular Name: (5Z)-2-(benzylamino)-5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethylene)thiazol-4-one (5Z)-2-(benzylamino)-5-(1H-pyrro…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.67 | 6.9 | -15.68 | 2 | 5 | 0 | 71 | 334.404 | 4 | ↓ |
Hi High (pH 8-9.5) | 2.67 | 5.92 | -44.62 | 1 | 5 | -1 | 73 | 333.396 | 4 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDC7-1-E | Cell Division Cycle 7-related Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9 | 0.47 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 50 | 0.43 | Binding ≤ 10μM |
CDK9-1-E | Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 15 | 0.46 | Binding ≤ 10μM |
KAPCA-1-E | CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 4), Eukaryotic | Eukaryotes | 50 | 0.43 | Binding ≤ 10μM |
Z81034-1-O | A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other | Other | 320 | 0.38 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KAPCA_HUMAN | P17612 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Human | 50 | 0.43 | Binding ≤ 1μM |
CDC7_HUMAN | O00311 | Cell Division Cycle 7-related Protein Kinase, Human | 9 | 0.47 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 50 | 0.43 | Binding ≤ 1μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 15 | 0.46 | Binding ≤ 1μM |
KAPCA_HUMAN | P17612 | CAMP-dependent Protein Kinase Alpha-catalytic Subunit, Human | 50 | 0.43 | Binding ≤ 10μM |
CDC7_HUMAN | O00311 | Cell Division Cycle 7-related Protein Kinase, Human | 9 | 0.47 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 50 | 0.43 | Binding ≤ 10μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 15 | 0.46 | Binding ≤ 10μM |
Z81034 | Z81034 | A2780 (Ovarian Carcinoma Cells) | 320 | 0.38 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of the pre-replicative complex | |
CDK-mediated phosphorylation and removal of Cdc6 | |
CREB phosphorylation through the activation of Adenylate Cyclase | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
DARPP-32 events | |
DNA Damage/Telomere Stress Induced Senescence | |
Factors involved in megakaryocyte development and platelet production | |
Formation of HIV elongation complex in the absence of HIV Tat | |
Formation of HIV-1 elongation complex containing HIV-1 Tat | |
Formation of RNA Pol II elongation complex | |
G0 and Early G1 | |
G2 Phase | |
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | |
Gluconeogenesis | |
HIV elongation arrest and recovery | |
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis | |
Interactions of Tat with host cellular proteins | |
Interleukin-3, 5 and GM-CSF signaling | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
Meiotic recombination | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
Pausing and recovery of HIV elongation | |
Pausing and recovery of Tat-mediated HIV elongation | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
PKA activation | |
PKA activation in glucagon signalling | |
PKA-mediated phosphorylation of CREB | |
PKA-mediated phosphorylation of key metabolic factors | |
Rap1 signalling | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of insulin secretion | |
Regulation of PLK1 Activity at G2/M Transition | |
RNA Polymerase II Pre-transcription Events | |
RNA Polymerase II Transcription Elongation | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
Tat-mediated elongation of the HIV-1 transcript | |
Tat-mediated HIV elongation arrest and recovery | |
Vasopressin regulates renal water homeostasis via Aquaporins | |
VEGFA-VEGFR2 Pathway |